Search alternatives:
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
-
18881
-
18882
-
18883
-
18884
Deforestation Impacts on Bat Functional Diversity in Tropical Landscapes
Published 2016“…We captured 906 bats (Phyllostomidae and Mormoopidae), including 10 genera and 12 species. …”
-
18885
Table_1_ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model.docx
Published 2022“…We reported that BMS-303141 administration could decrease the levels of serum lipid and renal lipogenic enzymes acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), HMG-CoA reductase (HMGCR), and diminish renal ELA in db/db mice. …”
-
18886
Image_1_ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model.tif
Published 2022“…We reported that BMS-303141 administration could decrease the levels of serum lipid and renal lipogenic enzymes acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), HMG-CoA reductase (HMGCR), and diminish renal ELA in db/db mice. …”
-
18887
Image_2_ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model.tif
Published 2022“…We reported that BMS-303141 administration could decrease the levels of serum lipid and renal lipogenic enzymes acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), HMG-CoA reductase (HMGCR), and diminish renal ELA in db/db mice. …”
-
18888
The morphogenesis and development of VM dopaminergic neurons is disturbed in <i>Dkk1<sup><b>−/−</b></sup></i> embryos.
Published 2011“…(B) Immunohistochemistry for TH in midbrain sections of <i>Dkk1<sup>−/−</sup></i> embryos revealed a decrease of aberrantly distributed dopaminergic neurons (upper panels) or an almost absence of dopaminergic neurons (bottom panels). …”
-
18889
Emodin suppresses HG-induced cFLIP generation but not repressing its activation and increasing degration.
Published 2014“…<p>(<b>a, b</b>) MCs were cultured in HG media and treated with 50 μM emodin for indicated times. …”
-
18890
Table_1_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials....
Published 2022“…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
-
18891
Table_2_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials....
Published 2022“…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
-
18892
Spontaneous bursting in model PCs.
Published 2024“…<i>a</i><sub><i>DK</i></sub> decreasing from 8000 to 6000 pA (8 to 6 nA) in steps of 500 pA, as indicated in (A.)…”
-
18893
<b>Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People with Obesity and Type 2 Diabetes</b>
Published 2024“…Here, we evaluated whether weight loss-induced improvements in insulin sensitivity were associated with changes in muscle sn-1,2-DAG and ceramide content in people with obesity and type 2 diabetes. …”
-
18894
-
18895
-
18896
-
18897
<i>N. meningitidis</i> infection of HBMEC causes degradation of occludin.
Published 2010“…A weak specific occludin fragment with an apparent molecular mass of 50–kDa is generated during infection at 24 h p.i. …”
-
18898
-
18899
-
18900